Page 97 - 81_02
P. 97

Carlos Fernández-Moriano et al.

(Ps) are probably due to the presence of alectoronic acid           Finally, it can be stated that tested lichen species
and protocetraric acid, respectively; both extracts contain     display promising neuroprotective properties, based on
atranorin as another secondary metabolite in an importance      their antioxidative effects, in nervous system cellular
proportion, so atranorin should also be taken into              model of excessive oxidative stress. Results suggest that
consideration when dealing with pharmacological                 the three species could be an interesting source of natural
properties. Regarding Usnea ghattensis methanol extract         products with neuroprotective interest; deeper
(Ug), usnic acid is present in similar concentration than       investigations may focus on the study of effects of isolated
other compounds belonging to the stictic acid complex           metabolites in other in vitro and in vivo models of
(consictic and stictic acid), and those metabolites could       neurodegeneration.
also contribute to the biological activities; then,
antioxidant capacity should not be only attributed to usnic     6. CONFLICT OF INTERESTS
acid in this specie.
                                                                The authors declare that there is no conflict of interests.
5. CONCLUSIONS
                                                                7. ACKNOWLEDGMENTS
    Methanol extracts of Cetrelia braunsiana, Parmotrema
saccatilobum and Usnea ghattensis have been investigated            This work was supported by a doctoral grant from the
for the first time regarding their neuroprotective activities,  Spanish Ministry of Education, Culture and Sports (FPU),
via antioxidant actions, in a model of oxidative stress in      awarded to Carlos Fernandez Moriano (N° FPU12/03824).
nervous system-like cells (neuron model); for such
purpose, the human astrocytoma SH-SY5Y cell line was            8. REFERENCIAS
chosen due to its extensive use as cellular model in
neuroprotection experiments, in both physiological and          1. Hawksworth DL, Honegger R. The lichen thallus: a
pathological conditions (42-44).
                                                                symbiotic phenotype of nutritionally specialized fungi
    Present study was initiated with a molecular
identification of 29 lichen species collected worldwide and     and its response to gall producers. In: Ed. Williams
belonging to Parmeliaceae family. After preparation of
methanol extracts from all specimens, antioxidant capacity      MA, Plant Galls. The Systematics Association,
was evaluated through ORAC assay, since antioxidation is
a considered mechanism for neuroprotection. Several             Special Vol. 49. Clarendon Press, Oxford. 1994: pp.
extracts demonstrated interesting radical scavenging
actions in that assay, and the three afore-mentioned species    77-98.
with higher potentials were chosen for cytoprotective
experiments on cellular substrate.                              2. Huneck S. The significance of lichens and their

    Through the MTT assay, optimal concentrations for           metabolites. Naturwissenschaften 1999; 86: 559-570.
each extract (0.5 µg/mL for Cb and Ug, and 0.25 µg/mL
for Ps) were selected in view of their cytoprotective results   3. Molnár K, Farkas E. Current results on biological
against H2O2, and then tested in the experiments
measuring oxidative stress markers. In general, our results     activities of lichen secondary metabolites: a review. Z
indicate that these Parmeliaceae lichens are able to reverse
H2O2-induced negative effects on redox status in neurons.       Naturforsch C 2010; 65: 157-173.
Usnea ghattensis appears to display the best protective
activity, since its extract was able to significantly decrease  4. Zambare VP, Christopher LP. Biopharmaceutical
intracellular ROS formation, attenuate changes in
glutathione system and decrease caspase-3 activity.             potential of lichens. Pharm Biol 2012; 50:778-798.

    Concerning the active constituents in the lichens,          5. Gómez-Serranillos MP, Fernández-Moriano C,
chemical composition was defined in order to identify the
major compounds in each extract. By TLC and HPLC, two           González-Burgos E, Divakar PK, Crespo A.
largely used methods in lichens phytochemistry (45), we
determined that the main constituents present in the three      Parmeliaceae      family:         phytochemistry,
extracts were alectoronic acid (Cb), protocetraric acid (Ps),
and usnic and stictic acids (Ug). All these secondary           pharmacological potential and phylogenetic features.
metabolites are biosynthesized through the polyketide
pathway and belong to the group of structures called            RSC Adv 2014; 4: 59017-59047.
depsidones, except usnic acid which is a dibenzofuran
compound. They might be responsible for the                     6. Behera BC, Verma N, Sonone A, Makhija U.
pharmacological properties demonstrated in the present
work, and therefore, they are worthy of further                 Antioxidant and antibacterial activities of lichen
investigation.
                                                                Usnea ghattensis in vitro, Biotechnol Lett 2005; 27:
    176
                                                                991-995.

                                                                7. Behera BC, Verma N, Sonone A, Makhija U.

                                                                Evaluation of antioxidant potential of the cultured

                                                                mycobiont of a lichen Usnea ghattensis. Phytother Res

                                                                2005; 19: 58-64.

                                                                8. Bugni TS, Andjelic CD, Pole AR, Rai P, Ireland CM,

                                                                Barrows LR. Biologically active components of a

                                                                Papua New Guinea analgesic and anti-inflammatory

                                                                lichen preparation. Fitoterapia. 2009; 80: 270-273.

                                                                9. Crespo A, Lumbsch HT. Cryptic species in lichen-

                                                                forming fungi. IMA Fungus 2010; 1: 167-170.

                                                                10. Crespo A, Divakar PK, Hawksworth DL. Generic

                                                                concepts in parmelioid lichens, and the phylogenetic

                                                                value of characters used in their circumscription.

                                                                Lichenologist 2011; 43: 511-535.

                                                                11. Divakar PK, Figueras G, Hladun N, Crespo A.

                                                                Molecular phylogenetic studies reveal an undescribed

                                                                species within the North American concept of

                                                                @Real Academia Nacional de Farmacia. Spain
   92   93   94   95   96   97   98   99   100   101   102